Log in to save to my catalogue

Post-exposure treatments for Ebola and Marburg virus infections

Post-exposure treatments for Ebola and Marburg virus infections

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1993013636

Post-exposure treatments for Ebola and Marburg virus infections

About this item

Full title

Post-exposure treatments for Ebola and Marburg virus infections

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2018-06, Vol.17 (6), p.413-434

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
The filoviruses, Ebola virus and Marburg virus, cause lethal haemorrhagic fever in humans and non-human primates (NHPs), and there are currently no licensed vaccines or treatments available for human use.
Death occurs in 90% or more of patients infected with Zaire ebolavirus (EBOV) if the viral load exceeds 6 log genome copies per...

Alternative Titles

Full title

Post-exposure treatments for Ebola and Marburg virus infections

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1993013636

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1993013636

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd.2017.251

How to access this item